FIELD: pharmaceutics.
SUBSTANCE: invention relates to specific analogues of diazonium amide, structure of which is given in patent claim. Disclosed compounds are used for preparing pharmaceutical composition, intended for use as antiproliferative agent containing therapeutically effective amount of compound in single dosage form with at least one pharmaceutically acceptable filler. Compounds are also used for relieving or treating cell proliferative disorder in individual.
EFFECT: new analogues of diazonium amide with antiproliferative action.
5 cl, 2 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS FOR USE THEREOF | 2015 |
|
RU2707280C2 |
| BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS FOR USE THEREOF | 2016 |
|
RU2712099C2 |
| TRICYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND USING THEM FOR TREATING IMMUNOLOGICAL AND ONCOLOGICAL COMPOUNDS | 2009 |
|
RU2545023C9 |
| NEUROACTIVE STEROIDS AND METHODS OF THEIR USE | 2014 |
|
RU2808166C2 |
| NEUROACTIVE STEROIDS AND METHODS FOR USE THEREOF | 2014 |
|
RU2684103C2 |
| FURO[3,2-B]PYRAN DERIVATIVES, APPLICABLE IN SYNTHESIS OF ANALOGUES | 2011 |
|
RU2579511C2 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND THEIR USE | 2014 |
|
RU2754534C2 |
| QUINOXALINE-CONTAINING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS | 2008 |
|
RU2493160C2 |
| MEK INHIBITORS AND THEIR THERAPEUTIC USE | 2021 |
|
RU2812929C1 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND THEIR USE | 2012 |
|
RU2808165C2 |
